A.J. Rice
Stock Analyst at UBS
(4.19)
# 456
Out of 5,109 analysts
260
Total ratings
62.57%
Success rate
9.86%
Average return
Main Sectors:
Stocks Rated by A.J. Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health | Maintains: Buy | $15 → $14 | $8.97 | +56.08% | 2 | Dec 18, 2025 | |
| PACS PACS Group | Reinstates: Buy | $50 → $42 | $37.31 | +12.57% | 2 | Dec 18, 2025 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $17 → $9 | $8.03 | +12.08% | 10 | Dec 9, 2025 | |
| SGRY Surgery Partners | Maintains: Buy | $34 → $29 | $15.64 | +85.48% | 2 | Nov 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Maintains: Neutral | $9 → $9.5 | $8.72 | +8.94% | 12 | Nov 7, 2025 | |
| AMN AMN Healthcare Services | Maintains: Neutral | $18 → $21 | $16.01 | +28.04% | 11 | Nov 7, 2025 | |
| ENSG The Ensign Group | Maintains: Buy | $205 → $220 | $176.66 | +24.53% | 4 | Nov 5, 2025 | |
| MD Pediatrix Medical Group | Maintains: Neutral | $17 → $23 | $21.78 | +5.60% | 19 | Nov 5, 2025 | |
| CNC Centene | Maintains: Neutral | $31 → $42 | $39.89 | +5.29% | 20 | Oct 30, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $238 → $260 | $197.77 | +31.47% | 12 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $302 | $227.08 | +32.99% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $42 | $37.73 | +11.32% | 6 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $22 | $19.64 | +12.02% | 12 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.2 → $3.6 | $3.21 | +12.15% | 8 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $95 | $78.31 | +21.31% | 13 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $150 | $107.11 | +40.04% | 9 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $435 → $425 | $343.30 | +23.80% | 5 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $145 | $111.03 | +30.60% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8.5 | $9.48 | -10.34% | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $14 | $14.84 | -5.66% | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $68 | $69.22 | -1.76% | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $38 → $40 | $32.35 | +23.65% | 2 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $450 → $485 | $826.43 | -41.31% | 1 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $95 | $14.30 | +564.34% | 13 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $311 → $316 | $474.06 | -33.34% | 12 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $96 | $79.12 | +21.33% | 6 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $635 → $575 | $259.25 | +121.79% | 9 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $590 → $610 | $327.58 | +86.21% | 12 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $308 → $305 | $254.46 | +19.86% | 4 | Nov 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $64 → $79 | $207.54 | -61.94% | 3 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $350 → $410 | $163.47 | +150.81% | 3 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $43 → $37 | $2.71 | +1,265.31% | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $158 → $143 | $175.92 | -18.71% | 9 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $270 | $274.86 | -1.77% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $0.57 | $27.64 | -97.94% | 3 | Jan 25, 2021 |
Ardent Health
Dec 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $8.97
Upside: +56.08%
PACS Group
Dec 18, 2025
Reinstates: Buy
Price Target: $50 → $42
Current: $37.31
Upside: +12.57%
Cross Country Healthcare
Dec 9, 2025
Maintains: Neutral
Price Target: $17 → $9
Current: $8.03
Upside: +12.08%
Surgery Partners
Nov 13, 2025
Maintains: Buy
Price Target: $34 → $29
Current: $15.64
Upside: +85.48%
Aveanna Healthcare Holdings
Nov 7, 2025
Maintains: Neutral
Price Target: $9 → $9.5
Current: $8.72
Upside: +8.94%
AMN Healthcare Services
Nov 7, 2025
Maintains: Neutral
Price Target: $18 → $21
Current: $16.01
Upside: +28.04%
The Ensign Group
Nov 5, 2025
Maintains: Buy
Price Target: $205 → $220
Current: $176.66
Upside: +24.53%
Pediatrix Medical Group
Nov 5, 2025
Maintains: Neutral
Price Target: $17 → $23
Current: $21.78
Upside: +5.60%
Centene
Oct 30, 2025
Maintains: Neutral
Price Target: $31 → $42
Current: $39.89
Upside: +5.29%
Tenet Healthcare
Oct 29, 2025
Maintains: Buy
Price Target: $238 → $260
Current: $197.77
Upside: +31.47%
Oct 29, 2025
Maintains: Buy
Price Target: $280 → $302
Current: $227.08
Upside: +32.99%
Oct 29, 2025
Maintains: Buy
Price Target: $35 → $42
Current: $37.73
Upside: +11.32%
Oct 28, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $19.64
Upside: +12.02%
Oct 27, 2025
Maintains: Neutral
Price Target: $3.2 → $3.6
Current: $3.21
Upside: +12.15%
Oct 13, 2025
Maintains: Buy
Price Target: $88 → $95
Current: $78.31
Upside: +21.31%
Oct 2, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $107.11
Upside: +40.04%
Sep 5, 2025
Maintains: Buy
Price Target: $435 → $425
Current: $343.30
Upside: +23.80%
Sep 2, 2025
Initiates: Buy
Price Target: $145
Current: $111.03
Upside: +30.60%
Aug 8, 2025
Maintains: Neutral
Price Target: $10 → $8.5
Current: $9.48
Upside: -10.34%
Aug 4, 2025
Maintains: Neutral
Price Target: $15 → $14
Current: $14.84
Upside: -5.66%
May 5, 2025
Maintains: Neutral
Price Target: $80 → $68
Current: $69.22
Upside: -1.76%
Apr 30, 2025
Upgrades: Buy
Price Target: $38 → $40
Current: $32.35
Upside: +23.65%
Aug 11, 2023
Maintains: Outperform
Price Target: $450 → $485
Current: $826.43
Upside: -41.31%
Jul 31, 2023
Reiterates: Outperform
Price Target: $95
Current: $14.30
Upside: +564.34%
Jul 28, 2023
Maintains: Outperform
Price Target: $311 → $316
Current: $474.06
Upside: -33.34%
May 8, 2023
Maintains: Outperform
Price Target: $125 → $96
Current: $79.12
Upside: +21.33%
Feb 6, 2023
Maintains: Outperform
Price Target: $635 → $575
Current: $259.25
Upside: +121.79%
Dec 7, 2022
Maintains: Outperform
Price Target: $590 → $610
Current: $327.58
Upside: +86.21%
Nov 23, 2022
Maintains: Outperform
Price Target: $308 → $305
Current: $254.46
Upside: +19.86%
Nov 22, 2022
Maintains: Neutral
Price Target: $64 → $79
Current: $207.54
Upside: -61.94%
Oct 27, 2022
Maintains: Outperform
Price Target: $350 → $410
Current: $163.47
Upside: +150.81%
Aug 4, 2022
Maintains: Neutral
Price Target: $43 → $37
Current: $2.71
Upside: +1,265.31%
Jul 22, 2022
Maintains: Neutral
Price Target: $158 → $143
Current: $175.92
Upside: -18.71%
Aug 6, 2021
Maintains: Outperform
Price Target: $300 → $270
Current: $274.86
Upside: -1.77%
Jan 25, 2021
Downgrades: Underperform
Price Target: $0.57
Current: $27.64
Upside: -97.94%